133 related articles for article (PubMed ID: 26258617)
1. Alteration of N-Glycan Profiles in Diabetic Retinopathy.
Inafuku S; Noda K; Amano M; Ohashi T; Yoshizawa C; Saito W; Murata M; Kanda A; Nishimura S; Ishida S
Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5316-22. PubMed ID: 26258617
[TBL] [Abstract][Full Text] [Related]
2. Short Communication: Increase of Sialylated N-Glycansin Eyes with Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy.
Inafuku S; Noda K; Amano M; Nishimura S; Ishida S
Curr Eye Res; 2016 May; 41(5):721-4. PubMed ID: 26177396
[TBL] [Abstract][Full Text] [Related]
3. Extracellular matrix proteins in epiretinal membranes and in diabetic retinopathy.
George B; Chen S; Chaudhary V; Gonder J; Chakrabarti S
Curr Eye Res; 2009 Feb; 34(2):134-44. PubMed ID: 19219685
[TBL] [Abstract][Full Text] [Related]
4. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
5. Elevated protein carbonyl and HIF-1α levels in eyes with proliferative diabetic retinopathy.
Loukovaara S; Koivunen P; Inglés M; Escobar J; Vento M; Andersson S
Acta Ophthalmol; 2014 Jun; 92(4):323-7. PubMed ID: 23718695
[TBL] [Abstract][Full Text] [Related]
6. Soluble IL-6 receptor in vitreous fluid of patients with proliferative diabetic retinopathy.
Kawashima M; Shoji J; Nakajima M; Kamura Y; Sato Y
Jpn J Ophthalmol; 2007; 51(2):100-4. PubMed ID: 17401618
[TBL] [Abstract][Full Text] [Related]
7. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
8. Comparisons of microRNA expression profiles in vitreous humor between eyes with macular hole and eyes with proliferative diabetic retinopathy.
Hirota K; Keino H; Inoue M; Ishida H; Hirakata A
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):335-42. PubMed ID: 24970617
[TBL] [Abstract][Full Text] [Related]
9. Human vitreal prostaglandin levels and proliferative diabetic retinopathy.
Douros S; Phillips BA; Nadel A; Obstbaum SA
Doc Ophthalmol; 2001 Jul; 103(1):27-34. PubMed ID: 11678158
[TBL] [Abstract][Full Text] [Related]
10. [Vitreous levels of stromal cell-derived factor-1 and vascular endothelial growth factor in diabetic retinopathy].
Chen L; Lü L; Li Y; Huang X; Zhang J; Li S
Yan Ke Xue Bao; 2008 Mar; 24(1):6-8. PubMed ID: 18709948
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of M-CSF and IL-13 in vitreous of patients with proliferative diabetic retinopathy: implications for M2 macrophage-involving fibrovascular membrane formation.
Yoshida S; Kobayashi Y; Nakama T; Zhou Y; Ishikawa K; Arita R; Nakao S; Miyazaki M; Sassa Y; Oshima Y; Izuhara K; Kono T; Ishibashi T
Br J Ophthalmol; 2015 May; 99(5):629-34. PubMed ID: 25355804
[TBL] [Abstract][Full Text] [Related]
12. Association of HMGB1 with oxidative stress markers and regulators in PDR.
Abu El-Asrar AM; Alam K; Garcia-Ramirez M; Ahmad A; Siddiquei MM; Mohammad G; Mousa A; De Hertogh G; Opdenakker G; Simó R
Mol Vis; 2017; 23():853-871. PubMed ID: 29259392
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-200b Expression in the Vitreous Humor of Patients with Proliferative Diabetic Retinopathy.
Gomaa AR; Elsayed ET; Moftah RF
Ophthalmic Res; 2017; 58(3):168-175. PubMed ID: 28571008
[TBL] [Abstract][Full Text] [Related]
14. Increased sCD200 Levels in Vitreous of Patients With Proliferative Diabetic Retinopathy and Its Correlation With VEGF and Proinflammatory Cytokines.
Xu Y; Cheng Q; Yang B; Yu S; Xu F; Lu L; Liang X
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6565-72. PubMed ID: 26457542
[TBL] [Abstract][Full Text] [Related]
15. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
16. Galectin-1 studies in proliferative diabetic retinopathy.
Abu El-Asrar AM; Ahmad A; Allegaert E; Siddiquei MM; Alam K; Gikandi PW; De Hertogh G; Opdenakker G
Acta Ophthalmol; 2020 Feb; 98(1):e1-e12. PubMed ID: 31318490
[TBL] [Abstract][Full Text] [Related]
17. Reduced concentrations of angiogenesis-related factors in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
Yoshida S; Ishikawa K; Matsumoto T; Yoshida A; Ishibashi T; Kono T
Graefes Arch Clin Exp Ophthalmol; 2010 Jun; 248(6):799-804. PubMed ID: 20135140
[TBL] [Abstract][Full Text] [Related]
18. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
19. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
Zheng B; Li T; Chen H; Xu X; Zheng Z
Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
[TBL] [Abstract][Full Text] [Related]
20. Intravitreous hepatocyte growth factor in patients with proliferative diabetic retinopathy: a case-control study.
Simó R; Vidal MT; García-Arumí J; Carrasco E; García-Ramírez M; Segura RM; Hernández C
Diabetes Res Clin Pract; 2006 Jan; 71(1):36-44. PubMed ID: 16029908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
